| Income Statement for Tapestry Pharmaceuticals Inc. (TPPH) | | | | | | | Income | in Thousands of Dollars | | | 12/2006 | 12/2005 | 12/2004 | 12/2003 | 12/2002 | | | Operating Revenue | - | - | - | - | 34,193 | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | 365 | 1,082 | 1,319 | 3,349 | (21,323) | | Gross Operating Profit | 365 | 1,082 | 1,319 | 3,349 | 12,870 | | | Selling/General/Admin Expense | (6,974) | (5,628) | (7,794) | (11,256) | (9,876) | | Research & Development | (10,389) | (10,630) | (13,504) | (9,890) | (16,112) | | EBITDA | (16,998) | (15,176) | (19,979) | (17,797) | (13,118) | | Depreciation & Amortization | (365) | (1,082) | (1,319) | (3,349) | (2,653) | | EBIT | (17,363) | (16,258) | (21,298) | (21,146) | (15,771) | | Interest Income | 1,296 | 731 | 694 | 110 | 267 | | Other Income, Net | - | - | - | - | 8,902 | | Total Income Avail For Interest Expense | (16,067) | (16,594) | (20,604) | (21,036) | (6,602) | | Interest Expense | (518) | (557) | (951) | (878) | (2,063) | | Pre-Tax Income | (16,585) | (17,151) | (21,555) | (21,914) | (8,665) | | Income Taxes | (8) | (29) | - | - | - | | Minority Interest | - | - | - | - | - | | Net Income from Continuing Operations | (16,593) | (17,180) | (21,555) | (21,914) | (8,665) | | Net Income from Discontinued Operations | (59) | (358) | (2,619) | 60,042 | - | | Net Income from Total Operations | (16,652) | (17,538) | (24,174) | 38,128 | (8,665) | | | Normalized Income | (16,593) | (16,113) | (21,555) | (21,914) | (8,665) | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | - | (1,067) | - | - | - | | Income from Cum. Effect of Acct Change | - | - | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | - | - | | Total Net Income | (16,652) | (17,538) | (24,174) | 38,128 | (8,665) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2006 | 12/2005 | 12/2004 | 12/2003 | 12/2002 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | - | - | | | Basic EPS from Continuing Operations | -1.29 | -5.04 | -6.60 | -7.10 | -2.90 | | Basic EPS from Discontinued Operations | 0.00 | -0.11 | -0.80 | 19.50 | 0.00 | | Basic EPS from Total Operations | -1.29 | -5.15 | -7.40 | 12.40 | -2.90 | | | Diluted EPS from Continuing Operations | -1.29 | -5.04 | -6.60 | -7.10 | -2.90 | | Diluted EPS from Discontinued Operations | 0.00 | -0.11 | -0.80 | 19.40 | 0.00 | | Diluted EPS from Total Operations | -1.29 | -5.15 | -7.40 | 12.30 | -2.90 | | | |
